Advertisement

Organisation › Details
Sartorius AG
Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, based in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide. Sartorius regularly expands its portfolio through the acquisition of complementary technologies. In 2023, the company generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees are working for customers around the globe. *
![]() |
Start | 1870-01-01 established |
Group | Sartorius (Group) | |
![]() |
Industry | laboratory equipment and instruments |
Industry 2 | precision instruments (excl laboratory) | |
![]() |
Person | Grosse, Michael (Sartorius 202507– CEO before Syntegon Technology + Tetra Pak + BMW + Ford) |
Person 2 | Lehmann, Rainer (Novonesis 202401 CFO before Sartorius 201703–202310 CFO before SVP Business Processes Unit ) | |
![]() |
Region | Göttingen |
Country | Germany | |
Street | 20 Otto-Brenner-Str. | |
City | 37079 Göttingen | |
Tel | +49-551-308-0 | |
Address record changed: 2024-05-24 | ||
Basic data | Employees | H: 10,001 to 50,00 (2022-12-31) |
Currency | EUR | |
Annual sales | 4,174,700,000 (sales revenue, consolidated (2022) 2022-12-31) | |
Profit | 913,100,000 (2022-12-31) | |
Cash | 165,900,000 (2022-12-31) | |
* Document for »About Section«: Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen. | ||
Record changed: 2024-12-29 |
Advertisement

More documents for Sartorius (Group)
- [1] Sartorius AG. (12/6/24). "Press Release: Michael Grosse to Succeed Joachim Kreuzburg as Chief Executive Officer of Sartorius AG". Göttingen....
- [2] Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen....
- [3] Sartorius AG. (6/5/24). "Press Release: Sartorius Opens New Center of Excellence for Bioanalytics in Ann Arbor". Ann Arbor, MI....
- [4] Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam....
- [5] Refeyn Ltd.. (5/22/24). "Press Release: Refeyn Announces Appointment of Fiona Coats as Chief Marketing Officer". Oxford....
- [6] Sartorius AG. (5/16/24). "Press Release: Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with Nvidia". Göttingen....
- [7] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
- [8] Sartorius AG. (4/9/24). "Press Release: Sartorius and TheWell Bioscience Partner to Enable more Accurate Predictions in Drug Discovery". Göttingen....
- [9] Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford....
- [10] Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top